Clinical Trial Update: Exemestane or Docetaxel-Cytoxan in Low Recurrence Score Cancers [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing exemestane to docetaxel plus cyclophosphamide in women with breast cancer and low recurrence score; the study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• Exemestane (Exemestane)

Snippet

Sponsor: Emory University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-10